Roger Kim, MD, MSCE, DAABIP, ATSF

Our @JAMANetworkOpen manuscript on annual #lungcancerscreening adherence and rates of cancer diagnosis highlights the importance of adherence as a quality metric for #lungcancerscreening programs. A thread 👇🏼👇🏼👇🏼

Pleased to share our latest @TheLancet manuscript led by @elo_chuqwu on keeping the focus of #lungcancerscreening on lives saved. sciencedirect.com/science/articl…

Register now to hear me share insights on #lungcancerscreening adherence at #ATS2026: ats2026.d365.events/education/sess…

Pleased to share our latest manuscript, “Lung Cancer Yield by Baseline Screening Lung-RADS Assignment and Patient Factors: The PROSPR-Lung Consortium,” now out in CHEST Pulmonary. chestpulmonary.org/article/S2949-…

Happy to share our latest manuscript: chestpulmonary.org/article/S2949-… We found that APP use of the @Optellum AI tool was associated with an increase diagnostic accuracy and malignant nodule high-risk classification and management with biopsy or surgical resection.

🚨e79 @AAB_IP now out! Important insights into IP clinical research with @RogerKimMD and Dr. David Ost. Do you have the right study for the question you want to answer? Listen to learn more!

Pleased to share my conversation with David Ost on Clinical Research Pearls and Pitfalls on the latest @AAB_IP podcast: youtu.be/qIbAJrdkkKM?si… @PC3Innovation @PennCancer @MDAndersonNews @SKAvasarala @bertsalguero

@LaurenGroner 😂🤣

My mentee just gets me 😁 #MiamiLife #BadBunny

@drmanaf12 @PC3Innovation @PennCancer @PennPulmonary Thanks for your interest! The link to the article is in my original tweet. It is open access so available for anyone to read.

@RogerKimMD @PC3Innovation @PennCancer @PennPulmonary There is a huge lung cancer disease burden in my part of the world.would be so grateful if you could share the article drmanaf12@gmail.com

Our review “Improving Lung Cancer Screening Diagnostic Efficiency” is now out in Current Opinion in Pulmonary Medicine: journals.lww.com/co-pulmonaryme… It is critical to optimize each step along the lung cancer diagnostic pathway to improve patient outcomes through early detection.

🚨@AAB_IP Podcast e78. Dr. AB Alraiyes breaks down practical, platform‑agnostic strategies to boost diagnostic yield in peripheral bronchoscopy. @atstoa @CHESTOncology @RogerKimMD @bertsalguero @Spotify - tinyurl.com/37k652hj @ApplePodcasts - tinyurl.com/bd443xn

📣📣 Happy to share our qualitative interview study evaluating clinicians’ approaches and perspectives on cancer risk assessment for individuals with pulmonary nodules: academic.oup.com/annalsats/adva… @PennCancer @PennPulmonary @PennMedicine @atstoa

The cold days of winter are upon us! Before you light your fireplace, check out some tips to keep your lungs safe from PC3I Faculty @RogerKimMD. More from @goodhousemag : goodhousekeeping.com/health/wellnes…

🚨@AAB_IP Podcast e77 🚨 CONFIRMing the future - Boosting robotic bronchoscopy with CT integration with Dr. @BryanHustaMD and Dr. Roberto Casal. @MayoClinic @MDAndersonNews @SKAvasarala @RogerKimMD @IntuitiveSurg Listen on @Spotify @AppleMusic (tinyurl.com/bdfayvfb)

Sign up now as either a Mentee or a Mentor for our @atstoa Mentoring Program!! Details here 👇👇👇 site.thoracic.org/membership/ass…

Honored to be a candidate to serve on the @atstoa Nominating Committee! Don’t forget to vote! 🙂

Pleased to share our latest work led by Debra Ritzwoller. At an integrated healthcare system, we found that #lungcancer #screening uptake was 37%, adherence was 62%, and the cancer detection rate was 5%. Outcomes varied with operational changes. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

@LaurenGroner @SylvesterCancer @UMiamiHealth @umiamimedicine @Latinamd @COlazagasti @Jani_Chinmay Congratulations!!

💥BIG NEWS: Pleased to share I’m joining @SylvesterCancer @UMiamiHealth @umiamimedicine as Associate Director of #LungCancerScreening + Associate Professor of Radiology (🫀🫁 division)! Stepping into my new role in early 2026 with immense gratitude and a collaborative spirit 🙏

@ChiFuJeffYang @C_MatheyAndrews @alexandra_p_24 @DeeptiSrini @mghctsurgery @MGHSurgery @MGHThoracicOnc @TomVargheseJr @LanaSchumacher_ @hibahealth @PriyankaSenth16 @arvindkumar_nyc @DrewMoghanaki Great work @ChiFuJeffYang and team!

Our team, led by Camille Mathey-Andrews (@C_MatheyAndrews), Alex Potter (@alexandra_p_24) and Deepti Srinivasan (@DeeptiSrini), published a study of segmentectomy vs lobectomy for patients with 2-3 cm non-small-cell lung cancer in Chest: authors.elsevier.com/c/1mEw52p-lGqG0 We found similar long-term survival between the two groups. In the post CALGB140503 / JCOG0802 era, is it time to consider a randomized trial in the U.S. comparing lobectomy vs sublobar resection for larger Stage I tumors?

An editorial from PC3I faculty @AnilVachani & @RogerKimMD & PC3I fellow Christopher Caruso outlines how the non-malignant resection rate can serve as a meaningful metric for balancing benefits and harms in #lungcancer screening. Read more @JACRJournal: sciencedirect.com/science/articl…

@LaurenGroner @drCarterBawa @JulieBartaMD @RandiMWilliams2 @ellakaz @NLCRTnews Wow, what a great crew!!

So inspiring to be surrounded by bold/brilliant women physicians and scientists leading national #lungcancer, #lungcancerscreening, and tobacco treatment efforts 🙌🤩💕 #NLCRT2025 @drCarterBawa @JulieBartaMD @RandiMWilliams2 @ellakaz @NLCRTnews